Showing results (1161-1170 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|July 5, 2021
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinomaOsamu Maehara, Goki Suda, Mitsuteru Natsuizaka, et al.Cancer Biology & Therapy|September 29, 2017
Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transitionJia Yang, Zhijun Chen, Xinyi Wang, et al.Cancer Biology & Therapy|October 12, 2017
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4Baoli Hu, Haifeng Zhang, Zuopei Wang, et al.Cancer Biology & Therapy|September 26, 2003
Novel anticancer agents in clinical developmentAlex A Adjei, Eric K RowinskyCancer Biology & Therapy|September 26, 2003
Angiogenesis inhibitors: a new class of drugsJudah FolkmanCancer Biology & Therapy|September 26, 2003
Evaluation of anti-tumor property of specific and non-specific BRMs in experimental gioma by assessing the microglial cell functional and phenotypic modulationsZarina Begum, Susobhan Sarkar, Joydeep Mukherjee, et al.Cancer Biology & Therapy|May 17, 2003
Mu-calpain activation in beta-lapachone-mediated apoptosisColleen Tagliarino, John J Pink, Kathryn E Reinicke, et al.Cancer Biology & Therapy|December 23, 2003
Egr1 signaling in prostate cancerEileen Adamson, Ian de Belle, Shalu Mittal, et al.Cancer Biology & Therapy|December 23, 2003
Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancerHiroyuki Matsubayashi, Noriyoshi Fukushima, Norihiro Sato, et al.Cancer Biology & Therapy|December 23, 2003
Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cellsTravis Hauguel, Fred BunzPageof 387